Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Issue of Equity

5 Apr 2024 15:49

RNS Number : 5598J
Maven Income and Growth VCT 5 PLC
05 April 2024
Β 

Maven Income and Growth VCT 5 PLC (the Company)

Β 

Issue of Equity

Β 

On 13 October 2023, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to Β£5 million, with an over-allotment facility for up to a further Β£2.5 million (the Offer).

Β 

Pursuant to the Offer, a total of Β£2,338,474 of valid applications were received in the period from 9.00am on 21 March 2024 up to and including 9.00am on 5 April 2024 in respect of the 2023/2024 tax year. This is the final allotment in respect of the 2023/2024 tax year and, as a result, the Company has issued and allotted 7,209,045 new Ordinary Shares on 5 April 2024. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 31.52p to 32.36p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 211,914,797. Therefore, the total number of voting rights in the Company is 211,914,797. The total amount raised by the Company for the 2023/2024 tax year to 5 April 2024 is Β£6,262,885.

Β 

In respect of this allotment, an application will be made by the Company to the FCA and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective, and dealings will commence, on or around 8 April 2024.

Β 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

The Board of the Company intends that an allotment in respect of applications for the 2024/2025 tax year will take place on, or around, 1 May 2024. For this allotment, and those made to date, the Company's Offer has received applications totalling Β£6,554,185.

Β 

For further information, please contact:

Β 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Β 

Maven Capital Partners UK LLP

Secretary

Β 

5 April 2024

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEQKPBQQBKDOQK
Date   Source Headline
12th May 20154:47 pmRNSDirector/PDMR Shareholding
12th May 20154:45 pmRNSTransaction in Own Shares
11th May 20154:49 pmRNSTransaction in Own Shares
28th Apr 20154:41 pmRNSNet Asset Value(s)
21st Apr 20153:08 pmRNSResult of AGM
13th Apr 20153:14 pmRNSIssue of Equity
6th Mar 20152:40 pmRNSAnnual Financial Report
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201511:50 amRNSDirector/PDMR Shareholding
26th Feb 201511:49 amRNSDirector/PDMR Shareholding
26th Feb 201511:46 amRNSDirector/PDMR Shareholding
20th Feb 20152:53 pmRNSIssue of Equity
17th Feb 20159:21 amRNSStatement re Offers and Related Party Transactions
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
28th Jan 20152:19 pmRNSNet Asset Value(s)
20th Jan 20159:48 amRNSStatement re Offers for Subscription
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
6th Jan 20154:47 pmRNSForm 8.3 - [Armour Group PLC] Replacement
6th Jan 201512:13 pmRNSForm 8 (DD) - Armour Group PLC
13th Nov 20142:31 pmRNSTransaction in Own Shares
6th Nov 20143:55 pmRNSTransaction in Own Shares
5th Nov 20144:20 pmRNSTransaction in Own Shares
4th Nov 201411:46 amRNSTransaction in Own Shares
3rd Nov 20143:59 pmRNSTransaction in Own Shares
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
9th Oct 201412:30 pmRNSInterim Management Statement
3rd Oct 20144:27 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
21st Aug 20141:09 pmRNSTransaction in Own Shares
14th Aug 20145:07 pmRNSTransaction in Own Shares
13th Aug 201412:27 pmRNSTransaction in Own Shares
12th Aug 20142:38 pmRNSTransaction in Own Shares
11th Aug 20144:08 pmRNSTransaction in Own Shares
5th Aug 201411:36 amRNSReplacement Director/PDMR Shareholding
1st Aug 20143:23 pmRNSDirector/PDMR Shareholding
1st Aug 20143:20 pmRNSDirector/PDMR Shareholding
1st Aug 20143:19 pmRNSDirector/PDMR Shareholding
30th Jul 201411:12 amRNSHalf Yearly Report
4th Jul 20144:34 pmRNSReplacement re Issue of Equity
3rd Jul 20144:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20149:51 amRNSIssue of Equity
28th May 20145:13 pmRNSOffer for Subscription Update
27th May 201410:35 amRNSDirector Declaration
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:52 pmRNSOffer for Subscription - Supplementary Prospectus
22nd Apr 20143:00 pmRNSResult of AGM
22nd Apr 20142:58 pmRNSDirectorate Change
17th Apr 20143:57 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.